References
- Wallace S. L., Singer J. Z. Review: systemic toxicity associated with the intravenous administration of colchicine—guidelines for use. J. Rheumatol. 1988; 15: 495–498
- Chang Y.-H., Silverman S. L., Paulus H. E. Colchicine. Drugs for Rheumatoid Disease, H. Paulus, D. Furst, S. Dromgoole. Churchill, Livingstone, New York 1987; 431–442
- Kaplan M. M., Ailing D., Zimmerman H. J., Wolke H. J., Sepersky R. A., Hirsch G. S., Elta G. H., Glick R. A., Eagen K. A. A prospective trial of colchicine for primary biliary cirrhosis. N. Engl. J. Med. 1986; 315: 1448–1454
- Robert W. N., Liang M. H., Stern S. H. Colchicine in acute gout. Reassessment of risks and benefits. JAMA 1987; 257: 1920–1922
- Malawista S. E. Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects. Arthritis Rheum. 1968; 11: 191–197
- Borisy G. G., Taylor E. W. The mechanism of action of colchicine. Binding of colchicine-3H to cellular protein. J. Cell Biol. 1967; 34: 525–533
- Wilson L., Friedkin M. The biochemical events of mitosis. II. The in vivo and in vitro binding of colchicine in grasshopper embryos and its possible relation to inhibition of mitosis. Biochemistry 1967; 6: 3126–3135
- Duijndam-van den Berge M., Goekoop J. G. Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia. J. Neurol. Neurosurg. Psychiatry 1986; 49: 595–598
- Fu T. K., Matsuyama S. S., Kessler J. O., Jarvick L. F. Philothermal response microtubules and dementia. Neurobiol. Aging 1968; 7: 41–43
- Iqbal K., Grundke-Iqbal I., Zaidi T., Merz P. A., Wen G. Y., Shaikh S. S., Wisneiwski H. M. Defective brain microtubule assembly in Alzheimer's disease. Lancet 1986; 2(8504)421–426
- Matsuyama S. S., Jarvick L. F. Hypothesis: microtubules, a key to Alzheimer disease. Proc. Natl. Acad. Sci. USA 1989; 86: 8152–8156
- Ruiz E. M., Ramirez C. A., Aponte M. A., Barbosa-Canovas G. V. Degradation of poly[bis(glycine ethyl ester)phosphazene] in aqueous media. Biomaterials 1993; 14: 491–496
- Wuthrich P., Ng B. K., Fritzinger K. V., Heller J. Pulsatile and delayed release of lysozymes from ointment-like poly (orthoesters). J. Controlled Release 1992; 21: 191–200
- Cohen S., Yoshioka T., Lucarelli M., Hwang L. H., Langer R. S. Controlled delivery systems for proteins based on poly (lactic/glycolic acid). Pharm. Res. 1991; 8: 713–720
- Laurencin C. T., Koh H. J., Neenan R. H., Allcock H. R., Langer R. Controlled release using a new bioerodible polyphosphazene matrix system. J. Biomed. Mater. Res. 1987; 21: 1231–1246
- Allcock H. R., Fuller T. J., Mack D. P., Matsumura K., Smeltz K. M. Synthesis of poly [(amino acid alkyl ester) phosphazenes]. Macromolecules 1977; 10: 824–830
- Allcock H. R., Fuller T. J. Synthesis and hydrolysis of hexakis (imidazolyl) cyclotriphosphazene. J. Am. Chem. Soc. 1981; 103: 2250–2256
- Grolleman C. W. J., deVisser A. C., Wolke J. G. C., van der Goot H., Timmerman H. Studies on a bioerodible drug carrier system based on PPHOS: Part I. Synthesis. J. Controlled Release 1986; 3: 143–154
- Elgendy H. M., Norman M. E., Keaton A. R., Laurencin C. T. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material. Biomaterials 1992; 14(4)263–268
- Guttman I., Wilks S. S., Hunter J. S. Introductory Engineering Statistics. John Wiley, New York 1982
- Laurencin C. T., Norman M. E., Elgendy H. M., El-Amin S. F., Allcock H. R., Pucher S. R., Ambrosio A. A. Use of polyphosphazenes for skeletal regeneration. J. Biomed. Mater. Res. 1993; 27: 963–73
- Ibim S. M., Ambrosio A., Larrier D., Allcock H. R., Laurencin C. T. Controlled macromolecule release from poly (phosphazene) matrices. J. Controlled Release 1996; 40: 31–39
- Drugs used in gout and hyperuricemia. AMA Drug Evaluations. American Medical Association, Chicago, IL 1983; 139–152